Status:

UNKNOWN

A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases

Lead Sponsor:

Zhejiang Zylox Medical Device Co., Ltd.

Conditions:

Peripheral Artery Disease

Eligibility:

All Genders

18-85 years

Phase:

NA

Brief Summary

This is a prospective, multicenter, randomized controlled trail using drug-coated balloon to treat below the knee arterial stenosis or occlusion.

Detailed Description

This trail is conducted in several centers all around China. 202 subjects with below the knee arterial stenosis or occlusion will be recruited and randomized, this trail compares the efficacy and safe...

Eligibility Criteria

Inclusion

  • Age 18-85 years;
  • ≥70% diameter stenosis or occlusion in the target below-the-knee lesion;
  • Rutherford Category 3-6;
  • Subjects are willing to sign informed consent;

Exclusion

  • Planned major limb amputation within 30 days after the procedure;
  • In-stent stenosis in the target lesion;
  • Severely calcified target lesions;
  • Creatinine\>2.5mg/dL;
  • History of allergies to anesthetics, contrast agents;
  • Subjects who have participated in any other drug or medical device clinical investigations and haven't reach the primary endpoint;
  • Other circumstances judged by researchers that are not suitable for enrollment.

Key Trial Info

Start Date :

March 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

202 Patients enrolled

Trial Details

Trial ID

NCT05415995

Start Date

March 1 2022

End Date

December 1 2024

Last Update

June 13 2022

Active Locations (20)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (20 locations)

1

The second hospital of Anhui Medical university

Hefei, Anhui, China

2

Zhongshan Hospital Xiamen University

Xiamen, Fujian, China

3

Hebei General Hospital

Shijiazhuang, Hebei, China

4

The First Hospital of Hebei Medical University

Shijiazhuang, Hebei, China